NL-OMON23975已完成不适用
Second serosurveillance study in the Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 study.
ational Institute for Public Health and the Environment (RIVM)0 个研究点目标入组 7,700 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 7,700
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Subject is part of the study sample;
- •2. Aged 0-79 years old;
排除标准
- •1 Subject is an employee of the RIVM.
研究者
相似试验
已完成
不适用
Second serosurveillance study in The Netherlands for the evaluation of the Dutch National Immunisation Programme: the PIENTER 2 studyISRCTN20164309ational Institute of Public Health and Environmental Protection (RIVM) (The Netherlands)7,700
已完成
不适用
Determine the appropriate age for a second immunization against MenC, an intervention study among Ducth adolescents.To determine the appropriate age during adolescence (10, 12 or 15 years) for a second Meningococcal serogroup C conjugate vaccination, the quality and quantity of the MenC-PS specific antibody response after the MenCC vaccination are studied.NL-OMON26279ational Institute for Public Health and Environment (RIVM, Bilthoven, The Netherlands)268
尚未招募
不适用
PIENTER-onderzoekThe age-specific seroprevalence (immunity) for diseases included in the NIP of the Dutch general populationNL-OMON24544ational Institute for Public Health and the Environment (RIVM)8,400
招募中
不适用
International Active Surveillance Study: Native Estrogen Estetrol (E4) Safety StudyBirth ControlContraceptionNCT06028555Center for Epidemiology and Health Research, Germany101,000
已完成
不适用
Surveillance study following the completion of "Peretinoin Phase2/3 study"hepatocellular carcinoma with HCV-RNA positiveJPRN-UMIN000006728Social insurance Alliance Shimonoseki Kohsei Hospital392